These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 7741790)

  • 21. [Relative bioavailability of the antiarrhythmia agent, tiracizine and its metabolites].
    Berndt A; Oertel R; Richter K; Terhaag B; Gramatté T
    Arzneimittelforschung; 1995 Mar; 45(3):250-3. PubMed ID: 7741778
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Pharmacokinetics and bioequivalence of various oral formulations of metoclopramide].
    Vergin H; Bishop-Freudling GB; Strobel K; Reeves DS
    Arzneimittelforschung; 1983; 33(3):458-62. PubMed ID: 6683523
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Study of the bioequivalence of a new isosorbide dinitrate tablet formulation compared with the standard preparation].
    Metzner JE; Buchberger D; Häring N; Läuter J
    Arzneimittelforschung; 1997 Jun; 47(6):719-26. PubMed ID: 9281301
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The pharmacokinetics, bioequivalence and bioavailability of different formulations of metoclopramide in man.
    Block W; Pingoud A; Khan M; Kjellerup P
    Arzneimittelforschung; 1981; 31(6):1041-5. PubMed ID: 7196237
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Comparison of the bioequivalence of two allopurinol preparations].
    Bührens K; Berndt P; Hilgenstock CM; Baumann W; Janzen D
    Arzneimittelforschung; 1991 Mar; 41(3):250-3. PubMed ID: 1867662
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Update on the statistical analysis of bioequivalence studies.
    Steinijans VW; Hauschke D
    Int J Clin Pharmacol Ther Toxicol; 1992; 30 Suppl 1():S45-50. PubMed ID: 1601531
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Update on the statistical analysis of bioequivalence studies.
    Steinijans VW; Hauschke D
    Int J Clin Pharmacol Ther Toxicol; 1990 Mar; 28(3):105-10. PubMed ID: 2318545
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Bioequivalence of an optimized doxycycline preparation].
    Lode H; Deppermann N; Schmidt U
    Arzneimittelforschung; 1989 Sep; 39(9):1162-5. PubMed ID: 2590269
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Proof of bioequivalence of two nifedipine preparations].
    Herrmann R; Rahlfs VW; Zimmermann H
    Arzneimittelforschung; 1989 Sep; 39(9):1143-8. PubMed ID: 2590266
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Study on the bioequivalence of two ranitidine formulations.
    Hilgenstock C; Schmiedel G; Bührens KG
    Arzneimittelforschung; 1987 Aug; 37(8):974-6. PubMed ID: 3675698
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Bioavailability of metoclopramide with special reference to relevant literature data].
    Berner G; Emschermann B; Gladtke E; Haase W; Leuschner F; Vögtle-Junkert U; Wagener HH
    Arzneimittelforschung; 1982; 32(2):169-73. PubMed ID: 7199924
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of formulation and food effect on the absorption of metoclopramide.
    Vergin H; Fisch U; Mahr G; Winterhalter B
    Int J Clin Pharmacol Ther; 2002 Apr; 40(4):169-74. PubMed ID: 11996211
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An approach to select the appropriate statistical method for testing bioequivalence.
    Steyn HS; Koeleman HA; Gouws E; Ritschel WA
    Int J Clin Pharmacol Ther Toxicol; 1991 Apr; 29(4):156-60. PubMed ID: 1822089
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of the pharmacokinetics of a new 30 mg modified-release tablet formulation of metoclopramide for once-a-day administration versus 10 mg immediate-release tablets: a single and multiple-dose, randomized, open-label, parallel study in healthy male subjects.
    Bernardo-Escudero R; Alonso-Campero R; Francisco-Doce MT; Cortés-Fuentes M; Villa-Vargas M; Angeles-Uribe J
    Eur J Drug Metab Pharmacokinet; 2012 Dec; 37(4):279-88. PubMed ID: 22328192
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bioavailability study of two different verapamil formulations.
    Horne C; Stenzhorn G; Blume H; Knauf H; Mutschler E
    Arch Pharm (Weinheim); 1992 Aug; 325(8):531-6. PubMed ID: 1417461
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The analysis of bioequivalence with respect to TMAX under a 2 x 2 crossover design.
    Have TR; Ten Chinchilli VM
    J Biopharm Stat; 1995 Jul; 5(2):185-99. PubMed ID: 7581427
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metoclopramide nasal spray in vitro evaluation and in vivo pharmacokinetic studies in dogs.
    Li Y; Fan X; Li W; Yang P; Zhang H; Tang D; Yin X; Sun J; Zheng A
    Pharm Dev Technol; 2018 Mar; 23(3):275-281. PubMed ID: 28379057
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of a controlled release hydrophilic matrix formulation for metoclopramide HCl.
    Hasan EI; Amro BI; Arafat T; Badwan AA
    Eur J Pharm Biopharm; 2003 May; 55(3):339-44. PubMed ID: 12754009
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro dissolution and urinary excretion study of metoclopramide tablets.
    Quiroga PA; Bustillo PM; Volonté MG
    Biopharm Drug Dispos; 1998 Oct; 19(7):479-82. PubMed ID: 9818715
    [No Abstract]   [Full Text] [Related]  

  • 40. An automated high-performance liquid chromatographic trace enrichment method for the determination of metoclopramide in serum and its application to a bioequivalence human volunteer study.
    Fairhead AP; Brooks SG; Butterworth KR; Mangham BA
    Food Chem Toxicol; 1989 May; 27(5):341-5. PubMed ID: 2744665
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.